These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22076422)

  • 41. Regression and shift in composition of coronary atherosclerotic plaques by pioglitazone: insight from an intravascular ultrasound analysis.
    Clementi F; Di Luozzo M; Mango R; Luciani G; Trivisonno A; Pizzuto F; Martuscelli E; Mehta JL; Romeo F
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):231-7. PubMed ID: 19262209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.
    Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Eur Heart J; 2013 Nov; 34(41):3182-90. PubMed ID: 23886915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
    Shukla A; Sharma MK; Jain A; Goel PK
    Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN.
    Stegman B; Puri R; Cho L; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nissen SE; Nicholls SJ
    Diabetes Care; 2014 Nov; 37(11):3114-20. PubMed ID: 25190674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology.
    Kovarnik T; Chen Z; Mintz GS; Wahle A; Bayerova K; Kral A; Chval M; Kopriva K; Lopez J; Sonka M; Linhart A
    Cardiovasc Diabetol; 2017 Dec; 16(1):156. PubMed ID: 29212544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statin therapy in patients with acute coronary syndrome: the JAPAN-ACS subanalysis study.
    Takashima H; Ozaki Y; Morimoto T; Kimura T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Daida H; Mizuno T; Asai K; Kuroda Y; Kosaka T; Kuhara Y; Kurita A; Maeda K; Amano T; Matsuzaki M;
    Circ J; 2012; 76(12):2840-7. PubMed ID: 22972364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
    Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
    N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.
    Iwata A; Miura S; Tanaka T; Ike A; Sugihara M; Nishikawa H; Kawamura A; Saku K
    Coron Artery Dis; 2012 Aug; 23(5):315-21. PubMed ID: 22617341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia.
    Kumar SS; Lahey KA; Day A; LaHaye SA
    Lipids Health Dis; 2009 Dec; 8():56. PubMed ID: 20017910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy.
    Takano M; Mizuno K; Yokoyama S; Seimiya K; Ishibashi F; Okamatsu K; Uemura R
    J Am Coll Cardiol; 2003 Aug; 42(4):680-6. PubMed ID: 12932601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Statin Plus Ezetimibe on Coronary Plaques in Acute Coronary Syndrome Patients with Diabetes Mellitus: Sub-Analysis of PRECISE-IVUS Trial.
    Fujisue K; Yamanaga K; Nagamatsu S; Shimomura H; Yamashita T; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Miyazaki T; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Sakamoto K; Izumiya Y; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
    J Atheroscler Thromb; 2021 Feb; 28(2):181-193. PubMed ID: 32435011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized evaluation of atorvastatin in patients with coronary heart disease: a serial intravascular ultrasound study.
    Yamada T; Azuma A; Sasaki S; Sawada T; Matsubara H;
    Circ J; 2007 Dec; 71(12):1845-50. PubMed ID: 18037734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vasa vasorum and plaque progression, and responses to atorvastatin in a rabbit model of atherosclerosis: contrast-enhanced ultrasound imaging and intravascular ultrasound study.
    Tian J; Hu S; Sun Y; Yu H; Han X; Cheng W; Ban X; Zhang S; Yu B; Jang IK
    Heart; 2013 Jan; 99(1):48-54. PubMed ID: 23100286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of ezetimibe/atorvastatin combination on oxidized low density lipoprotein cholesterol in patients with coronary artery disease or coronary artery disease equivalent.
    Azar RR; Badaoui G; Sarkis A; Azar M; Aydanian H; Harb S; Achkouty G; Kassab R
    Am J Cardiol; 2010 Jul; 106(2):193-7. PubMed ID: 20599002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
    Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
    Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
    Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency and evolution of thin-capped fibroatheromas in left main coronary artery as assessed by serial virtual histology intravascular ultrasound analysis.
    Kim SW; Mintz GS; Weissman NJ; Lee WS; Senguttuvan NB; Kwon JE; Kim H; Seo JS; Seok JW; Kim EY; Hyeon SH; Hong JH; Kim CJ; Cho DY; Kim TH
    J Invasive Cardiol; 2014 Apr; 26(4):175-9. PubMed ID: 24717275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Ezetimibe on Stabilization and Regression of Intracoronary Plaque　- The ZIPANGU Study.
    Ueda Y; Hiro T; Hirayama A; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K;
    Circ J; 2017 Oct; 81(11):1611-1619. PubMed ID: 28592751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.